Blueshift Asset Management’s Integra LifeSciences IART Stock Holding History

Blueshift Asset Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-18,435	Closed	-$226K	–	530
2025 Q2	$226K	Buy	+18,435	New	+$268K	0.07%	363
2022 Q2	–	Sell	-10,106	Closed	-$649K	–	827
2022 Q1	$649K	Buy	+10,106	New	+$665K	0.06%	357
2021 Q3	–	Sell	-8,803	Closed	-$601K	–	1133
2021 Q2	$601K	Buy	+8,803	New	+$623K	0.03%	509
2020 Q1	–	Sell	-5,633	Closed	-$328K	–	426
2019 Q4	$328K	Buy	+5,633	New	+$335K	0.04%	579
2019 Q1	–	Sell	-5,096	Closed	-$230K	–	821
2018 Q4	$230K	Buy	+5,096	New	+$280K	0.04%	548

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Blueshift Asset Management's IART Position: Q3 2025 in Review

Blueshift Asset Management sold out of Integra LifeSciences (IART) in Q3 2025, closing a stake of 18,435 shares — an estimated $226K sold.

Blueshift Asset Management first reported a position in IART in Q4 2018 and held it in 5 quarters. The position peaked at $649K in Q1 2022. 207 funds tracked by Wall St. Rank hold IART as of Q3 2025.

Blueshift Asset Management reported no remaining Integra LifeSciences position as of Q3 2025 after selling out during the quarter.
Blueshift Asset Management sold 18,435 Integra LifeSciences shares in Q3 2025, an estimated $226K.
Blueshift Asset Management first reported a position in Integra LifeSciences in Q4 2018 and held it in 5 quarters.
Blueshift Asset Management's Integra LifeSciences position peaked at $649K in Q1 2022.
207 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2025.

Based on Blueshift Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.